UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Detalus Advisors LLC

Detalus Advisors LLC grew its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% during the 3rd quarter, Holdings Channel reports. The fund owned 1,673 shares of the healthcare conglomerate’s stock after purchasing an additional 28 shares during the period. Detalus Advisors LLC’s holdings in UnitedHealth Group were worth $978,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also recently made changes to their positions in the company. Swedbank AB purchased a new stake in UnitedHealth Group during the first quarter worth $1,117,462,000. Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in shares of UnitedHealth Group by 107.8% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 2,306,729 shares of the healthcare conglomerate’s stock valued at $1,141,113,000 after purchasing an additional 1,196,758 shares in the last quarter. Lone Pine Capital LLC purchased a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $480,903,000. Dimensional Fund Advisors LP lifted its position in shares of UnitedHealth Group by 30.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after buying an additional 880,183 shares in the last quarter. Finally, Baillie Gifford & Co. increased its holdings in UnitedHealth Group by 1,125.4% in the 2nd quarter. Baillie Gifford & Co. now owns 894,006 shares of the healthcare conglomerate’s stock worth $455,281,000 after acquiring an additional 821,050 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.9 %

NYSE UNH opened at $564.48 on Thursday. The firm’s 50-day moving average is $584.16 and its two-hundred day moving average is $536.49. The stock has a market capitalization of $521.25 billion, a P/E ratio of 36.77, a PEG ratio of 1.67 and a beta of 0.58. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion for the quarter, compared to analyst estimates of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm’s quarterly revenue was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the company earned $6.56 earnings per share. On average, sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Investors of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on UNH shares. Morgan Stanley cut their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their price target on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. UBS Group decreased their price objective on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Stephens reduced their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating for the company in a research report on Wednesday, October 16th. Finally, Truist Financial reaffirmed a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.